West Pharmaceutical Reports Higher First-Quarter Revenue, Earnings
EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) reported first-quarter 2026 net sales of $844.9 million and diluted earnings per share of $1.92, reflecting increases of 21.0% and 56.1%, …
West Pharmaceutical Reports Higher First-Quarter Revenue, Earnings Read More